Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 93

1.

Corticosteroid therapy for hearing and balance disorders.

Trune DR, Canlon B.

Anat Rec (Hoboken). 2012 Nov;295(11):1928-43. doi: 10.1002/ar.22576. Epub 2012 Oct 8. Review.

2.

Mineralocorticoid receptor mediates glucocorticoid treatment effects in the autoimmune mouse ear.

Trune DR, Kempton JB, Gross ND.

Hear Res. 2006 Feb;212(1-2):22-32. Epub 2005 Nov 22.

PMID:
16307853
3.

Blocking the glucocorticoid receptor with RU-486 does not prevent glucocorticoid control of autoimmune mouse hearing loss.

Trune DR, Kempton JB.

Audiol Neurootol. 2009;14(6):423-31. doi: 10.1159/000241899. Epub 2009 Nov 16.

4.
5.

Low dose combination steroids control autoimmune mouse hearing loss.

Trune DR, Kempton JB.

J Neuroimmunol. 2010 Dec 15;229(1-2):140-5. doi: 10.1016/j.jneuroim.2010.07.026. Epub 2010 Aug 30.

6.

Spironolactone blocks glucocorticoid-mediated hearing preservation in autoimmune mice.

Gross ND, Kempton JB, Trune DR.

Laryngoscope. 2002 Feb;112(2):298-303.

PMID:
11889387
8.

Intratympanic dexamethasone and hyaluronic acid in patients with low-frequency and Ménière's-associated sudden sensorineural hearing loss.

Selivanova OA, Gouveris H, Victor A, Amedee RG, Mann W.

Otol Neurotol. 2005 Sep;26(5):890-5.

PMID:
16151334
9.

[Long-term efficacy of triple semicircular canal occlusion in the treatment of intractable Meniere's disease].

Zhang D, Fan Z, Han Y, Li Y, Wang H.

Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi. 2015 Sep;50(9):733-7. Chinese.

PMID:
26696345
10.

Analysis of audio-vestibular assessment in acute low-tone hearing loss.

Im GJ, Kim SK, Choi J, Song JJ, Chae SW, Jung HH.

Acta Otolaryngol. 2016 Jul;136(7):649-54. doi: 10.3109/00016489.2016.1152506. Epub 2016 Mar 10.

PMID:
26963446
11.

Oral steroid treatment for hearing improvement in Ménière's disease and endolymphatic hydrops.

Fisher LM, Derebery MJ, Friedman RA.

Otol Neurotol. 2012 Dec;33(9):1685-91. doi: 10.1097/MAO.0b013e31826dba83.

PMID:
23047260
12.

Intratympanic dexamethasone for sudden sensorineural hearing loss after failure of systemic therapy.

Haynes DS, O'Malley M, Cohen S, Watford K, Labadie RF.

Laryngoscope. 2007 Jan;117(1):3-15. Review.

PMID:
17202923
13.

Positive pressure therapy for Ménière's disease or syndrome.

van Sonsbeek S, Pullens B, van Benthem PP.

Cochrane Database Syst Rev. 2015 Mar 10;(3):CD008419. doi: 10.1002/14651858.CD008419.pub2. Review.

PMID:
25756795
14.

Outcomes of endolymphatic shunt surgery for Ménière's disease: comparison with intratympanic gentamicin on vertigo control and hearing loss.

Derebery MJ, Fisher LM, Berliner K, Chung J, Green K.

Otol Neurotol. 2010 Jun;31(4):649-55. doi: 10.1097/MAO.0b013e3181dd13ac.

PMID:
20431498
15.

Use of streptomycin sulfate in the treatment of Meniere's disease.

Silverstein H, Hyman SM, Feldbaum J, Silverstein D.

Otolaryngol Head Neck Surg. 1984 Apr;92(2):229-32.

PMID:
6425780
16.

Glucocorticoid impact on cochlear function and systemic side effects in autoimmune C3.MRL-Faslpr and normal C3H/HeJ mice.

Trune DR, Kempton JB, Harrison AR, Wobig JL.

Hear Res. 2007 Apr;226(1-2):209-17. Epub 2006 Nov 13.

PMID:
17098384
17.

Steroids for treatment of sudden sensorineural hearing loss: a meta-analysis of randomized controlled trials.

Crane RA, Camilon M, Nguyen S, Meyer TA.

Laryngoscope. 2015 Jan;125(1):209-17. doi: 10.1002/lary.24834. Epub 2014 Jul 21.

PMID:
25045896
18.

Protective effects of corticosteroids and neurosteroids on cochlear injury.

Tabuchi K, Nakamagoe M, Nishimura B, Hayashi K, Nakayama M, Hara A.

Med Chem. 2011 Mar;7(2):140-4. Review.

PMID:
21222613
19.

Procedures for restoring vestibular disorders.

Walther LE.

GMS Curr Top Otorhinolaryngol Head Neck Surg. 2005;4:Doc05. Epub 2005 Sep 28.

20.

Protecting the auditory system with glucocorticoids.

Meltser I, Canlon B.

Hear Res. 2011 Nov;281(1-2):47-55. doi: 10.1016/j.heares.2011.06.003. Epub 2011 Jun 21. Review.

PMID:
21718769

Supplemental Content

Support Center